Inve US ▾

Constellium (CSTM) earnings

CONSTELLIUM SE· Materials

Results to
Mar 2026
Latest analysed call
Jun 2026 (Q2 FY26)
Balance sheet to
Dec 2025

Company research is public. Sign in to keep your own companies, notes and cases.

Constellium earnings: last reported Wed, 29 Jul 2026, for the quarter ended Jun 2026.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue2,461 $ million+24.4% YoYQuarterly, as filedQuarter to Mar 2026Revenue from operations as filed.
Operating marginUnavailable—Operating profit / revenueQuarter to Mar 2026Not in the filed figures for the quarter to mar 2026. No older figure is substituted.
Net profit199 $ million+437.8% YoYQuarterly, as filedQuarter to Mar 2026Profit after tax as filed.

Source: Inve data from filed results (SEC filings) · to Mar 2026

Guidance

What management said, and what became of it

9 of 10 judged targets kept · 25 open · verdicts reflect calls analysed to Jun 2026.

TargetOriginal wordingSaidLatest callVerdict
Third Airware casthouse at Issoire to start upstart-up by the end of 2026Dec 2025Jun 2026:I'm pleased to announce the cast house is up and running, and we have begun customer qualifications
Call transcript, Jun 2026 · no direct link
Achieved
Full-year 2026 adjusted EBITDA (excluding noncash metal price lag)$780 million to $820 millionDec 2025Jun 2026:we are now targeting adjusted EBITDA, excluding the non-cash impact of metal price lag in the range of $980 million to $1.02 billion
Call transcript, Jun 2026 · no direct link
Revised Up
Full-year 2026 capital expenditureapproximately $315 million (transcript garbled as $115 million)Dec 2025Jun 2026:We expect CapEx to be approximately $330 million
Call transcript, Jun 2026 · no direct link
On Track

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

1 of CONSTELLIUM SE's 35 targets was missed. See which ones, and which are quietly gone. The 3 above are the free sample; 32 more targets are in the full ledger.

Create a free account Free account: 5 full ledgers a month and one Inve Case. US Pro opens 100 a month: first month free, no card.
See the full record

Price

$25.47 +0.39% · +$0.1

Last close Oct 15, 2026 · US · USD

Performance +66.3% 1Y

$15.0$20.0$25.0$30.0$35.0Oct 25Nov 25Jan 26Feb 26Apr 26May 26Jul 26Aug 26Oct 26Mar 2026 (Q1 FY26) — 29 Apr 2026Jun 2026 (Q2 FY26) — 29 Jul 2026

1Y: $15.32 on 14 Oct 2025 → $25.47. High $36.15 (4 Jun 2026), low $14.75 (18 Nov 2025).

Previous close
$25.37
52-week range
$14.75 – $36.15
One year
+60.09%

Overview

Symbol
CSTM
Sector
Materials
Exchange
US
Currency
USD

Your own record

Start an Inve Case for CONSTELLIUM SE

Free account. Everything above stays public.

Write why you follow CONSTELLIUM SE and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.